240
Participants
Start Date
June 30, 2005
Primary Completion Date
August 31, 2006
Study Completion Date
August 31, 2006
Lonidamine
New York University School of Medicine, New York
Weill Medical College of Cornell University, New York
Accumed Research Associates, Garden City
State College Urologic Associates, State College
Urological Associates of Lancaster, Lancaster
Werner, Murdock & Francis, PA, Urology Associates, Greenbelt
Radiant Research, Greer, Greer
South Florida Medical Research, Aventura
Tampa Bay Medical Research, Clearwater
Florida Healthcare Research, Ocala
Radiant Research. Columbus, Columbus
Northeast Indiana research, LLC, Fort Wayne
Metropolitan Urology, Jeffersonville
Midwest Prostate & Urology Health Center, Chicago
Specialty Care Research, Peoria
UT Southwestern Medical Center at Dallas, Dept of Urology, Dallas
Accelovance, Houston
Baylor College of Medicine, Scott Department of Urology, Houston
Urology San Antonio Research, San Antonio
Urology Research Options, Aurora
Advanced Clinical Therapeutics, Tucson
Sheldon J. Freedman, MD Ltd., Las Vegas
Urological Sciences Research Foundation, Culver City
Atlantic Urological Medical Group, Long Beach
San Diego Uro-Research, San Diego
California Professional Research, Newport Beach
Chris B. Threatt, MD Inc., Atherton
Stanford University Hospital, Stanford
Integrity Medical Research, LLC, Mountlake Terrace
Connecticut Clinical Research Center Urology Specialists, Waterbury
Delaware Valley Clinical Research, Cherry Hill
Lawrenceville Urology, Lawrenceville
Urology Healthcare Associates, Woodlane
University Urological Research Institute, Providence
Lead Sponsor
Threshold Pharmaceuticals
INDUSTRY